BD (Becton, Dickinson and Company), has launched a new patient safety programme for hospitals, called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME). Aimed at addressing the two critical challenges in a hospital setting – infection prevention and medication safety – PRIME is developed by Joint Commission International for Patient Safety, with sponsorship by BD. This new unique programmematic approach towards patient safety will be implemented over a six-month duration, composed of goal-setting, constant progress review, tele-consultations with experts and scientific updates through webinars. Hospitals will be certified upon successful completion of the programme. As of now the hospitals that have signed up for the programme in India are:
Kolkata – Belle Vue Clinic, Fortis Hospital Anandapur
Mumbai – Breach Candy, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute
Trivandrum – Kerala Institute of Medical Sciences
Manipal – Kasturba Hospital
Mohali – Fortis Hospital
Delhi/NCR – Max Healthcare, Saket and Medanta The Medicity-Gurgaon
PRIME has been launched across South Korea, Japan, Malaysia, Thailand, Indonesia, Philippines, Vietnam and India.